4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-019671
Director sold 5,000 shares at $85.76 ($428,800)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BEHRENS M KATHLEEN · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-10 | Exercise or conversion : show line 1 in the form | +5,000 | $42.30 | $211,500 | 135,517 | D |
| 2021-03-10 | Sale : show line 2 in the form | −5,000 | $85.76 | $428,800 | 130,517 | D |
| Open-market sales · 5,000 sh · avg $85.76 · $428,800 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-10 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −5,000 | 0 | D |
Loading xslF345X03/doc4.xml…